The ANKS1B gene and its associated phenotypes: focus on CNS drug response.

The ANKS1B gene was a top finding in genome-wide association studies (GWAS) of antipsychotic drug response. Subsequent GWAS findings for ANKS1B include cognitive ability, educational attainment, body mass index, response to corticosteroids and drug dependence. We review current human association evidence for ANKS1B, in addition to functional studies that include two published mouse knockouts. The several GWAS findings in humans indicate that phenotypically relevant variation is segregating at the ANKS1B locus. ANKS1B shows strong plausibility for involvement in CNS drug response because it encodes a postsynaptic effector protein that mediates long-term changes to neuronal biology. Forthcoming data from large biobanks should further delineate the role of ANKS1B in CNS drug response.

[1]  Peer Bork,et al.  SMART: recent updates, new developments and status in 2020 , 2020, Nucleic Acids Res..

[2]  Suhua Chang,et al.  Genome-wide association study identifies common genetic risk factors for alcohol, heroin and methamphetamine dependence , 2018, bioRxiv.

[3]  J. Potash,et al.  Integrating brain methylome with GWAS for psychiatric risk gene discovery , 2018, bioRxiv.

[4]  H. Hakonarson,et al.  Common and Rare Genetic Risk Factors Converge in Protein Interaction Networks Underlying Schizophrenia , 2018, Front. Genet..

[5]  Thomas J Hoffmann,et al.  A Large Multiethnic Genome-Wide Association Study of Adult Body Mass Index Identifies Novel Loci , 2018, Genetics.

[6]  Jonathan P. Beauchamp,et al.  Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals , 2018, Nature Genetics.

[7]  M. Pirmohamed,et al.  Susceptibility to corticosteroid-induced adrenal suppression: a genome-wide association study , 2018, The Lancet. Respiratory medicine.

[8]  Stuart J. Ritchie,et al.  Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function , 2018, Nature Communications.

[9]  P. Visscher,et al.  Meta-analysis of genome-wide association studies for height and body mass index in ∼700,000 individuals of European ancestry , 2018, bioRxiv.

[10]  Warren W. Kretzschmar,et al.  Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression , 2017, Nature Genetics.

[11]  Shiva M. Singh,et al.  Post-zygotic genomic changes in glutamate and dopamine pathway genes may explain discordance of monozygotic twins for schizophrenia , 2017, Clinical and Translational Medicine.

[12]  A. Ekici,et al.  High resolution chromosomal microarray analysis in paediatric obsessive-compulsive disorder , 2017, BMC Medical Genomics.

[13]  H. Meltzer,et al.  Genetic predictors of antipsychotic response to lurasidone identified in a genome wide association study and by schizophrenia risk genes , 2017, Schizophrenia Research.

[14]  C. Ballantyne,et al.  Endothelial LRP1 regulates metabolic responses by acting as a co-activator of PPARγ , 2017, Nature Communications.

[15]  Seung-Gul Kang,et al.  rs7968606 polymorphism of ANKS1B is associated with improvement in the PANSS general score of schizophrenia caused by amisulpride , 2017, Human psychopharmacology.

[16]  A. Hofman,et al.  Meta-analysis of genome-wide association studies on the intolerance of angiotensin-converting enzyme inhibitors , 2017, Pharmacogenetics and genomics.

[17]  J. McClay,et al.  Initial characterization of behavior and ketamine response in a mouse knockout of the post-synaptic effector gene Anks1b , 2017, Neuroscience Letters.

[18]  R. Alisch,et al.  Early-life stress links 5-hydroxymethylcytosine to anxiety-related behaviors , 2017, Epigenetics.

[19]  Markus Perola,et al.  Genome-wide Association Study Identifies 27 Loci Influencing Concentrations of Circulating Cytokines and Growth Factors. , 2017, American journal of human genetics.

[20]  S. Keleş,et al.  Sex-specific hippocampal 5-hydroxymethylcytosine is disrupted in response to acute stress , 2016, Neurobiology of Disease.

[21]  N. Schork,et al.  Genome-wide association study of paliperidone efficacy , 2016, Pharmacogenetics and genomics.

[22]  W. Drevets,et al.  Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response , 2016, Translational psychiatry.

[23]  N. Eriksson,et al.  Genome-wide association and HLA region fine-mapping studies identify susceptibility loci for multiple common infections , 2016, Nature Communications.

[24]  R. Weinberg,et al.  The Postsynaptic Density: There Is More than Meets the Eye , 2016, Front. Synaptic Neurosci..

[25]  K. Bayer,et al.  CaMKII‐mediated displacement of AIDA‐1 out of the postsynaptic density core , 2016, FEBS letters.

[26]  I. Imoto,et al.  Calcium Signaling Pathway Is Associated with the Long-Term Clinical Response to Selective Serotonin Reuptake Inhibitors (SSRI) and SSRI with Antipsychotics in Patients with Obsessive-Compulsive Disorder , 2016, PloS one.

[27]  T. Foster,et al.  Transcription Profile of Aging and Cognition-Related Genes in the Medial Prefrontal Cortex , 2016, Front. Aging Neurosci..

[28]  C. Spencer,et al.  A contribution of novel CNVs to schizophrenia from a genome-wide study of 41,321 subjects: CNV Analysis Group and the Schizophrenia Working Group of the Psychiatric Genomics Consortium , 2016, bioRxiv.

[29]  M. Lauriola,et al.  Towards the emerging crosstalk: ERBB family and steroid hormones. , 2016, Seminars in cell & developmental biology.

[30]  J A Badner,et al.  Chronic behavioral stress exaggerates motor deficit and neuroinflammation in the MPTP mouse model of Parkinson's disease , 2016, Translational Psychiatry.

[31]  Vladimir Vacic,et al.  Genome‐wide association study of schizophrenia in Ashkenazi Jews , 2015, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[32]  J. Kelsoe,et al.  RNA sequencing of transcriptomes in human brain regions: protein-coding and non-coding RNAs, isoforms and alleles , 2015, BMC Genomics.

[33]  T. Reese,et al.  AIDA-1 Moves out of the Postsynaptic Density Core under Excitatory Conditions , 2015, PloS one.

[34]  K. Becker,et al.  Experience Modulates the Effects of Histone Deacetylase Inhibitors on Gene and Protein Expression in the Hippocampus: Impaired Plasticity in Aging , 2015, The Journal of Neuroscience.

[35]  Nora D. Volkow,et al.  The Brain on Drugs: From Reward to Addiction , 2015, Cell.

[36]  P. Castillo,et al.  ANKS1B Gene Product AIDA-1 Controls Hippocampal Synaptic Transmission by Regulating GluN2B Subunit Localization , 2015, The Journal of Neuroscience.

[37]  A. Sharp,et al.  Genome-Wide DNA Methylation Profiling Reveals Epigenetic Changes in the Rat Nucleus Accumbens Associated With Cross-Generational Effects of Adolescent THC Exposure , 2015, Neuropsychopharmacology.

[38]  S. Markey,et al.  Quantitative mass spectrometry measurements reveal stoichiometry of principal postsynaptic density proteins. , 2015, Journal of proteome research.

[39]  Ross M. Fraser,et al.  Genetic studies of body mass index yield new insights for obesity biology , 2015, Nature.

[40]  Michael Snyder,et al.  Integrated systems analysis reveals a molecular network underlying autism spectrum disorders , 2014, Molecular systems biology.

[41]  W. Iacono,et al.  Heritability and molecular genetic basis of electrodermal activity: a genome-wide association study. , 2014, Psychophysiology.

[42]  Peer Bork,et al.  SMART: recent updates, new developments and status in 2015 , 2014, Nucleic Acids Res..

[43]  C. Spencer,et al.  Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.

[44]  M. De Iorio,et al.  Genome-Wide Data reveals Novel Genes for Methotrexate Response in a Large Cohort of Juvenile Idiopathic Arthritis Cases , 2014, The Pharmacogenomics Journal.

[45]  A. Lu,et al.  Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid , 2014, Molecular Psychiatry.

[46]  Eric S. Lander,et al.  A polygenic burden of rare disruptive mutations in schizophrenia , 2014, Nature.

[47]  M. Filla,et al.  Dexamethasone increases αvβ3 integrin expression and affinity through a calcineurin/NFAT pathway. , 2013, Biochimica et biophysica acta.

[48]  E. J. van den Oord,et al.  Testing two models describing how methylome-wide studies in blood are informative for psychiatric conditions. , 2013, Epigenomics.

[49]  A. Kurabi,et al.  Solution Structure and Peptide Binding of the PTB Domain from the AIDA1 Postsynaptic Signaling Scaffolding Protein , 2013, PloS one.

[50]  Joo-Yong Lee,et al.  Clusterin and LRP2 are critical components of the hypothalamic feeding regulatory pathway , 2013, Nature Communications.

[51]  M. Daly,et al.  Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis , 2013, The Lancet.

[52]  Martin Engel,et al.  Neuregulin-1 signalling and antipsychotic treatment , 2013, Psychopharmacology.

[53]  Carl D Langefeld,et al.  Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1 , 2013, Neurobiology of Aging.

[54]  Jack Y. Yang,et al.  Genome-wide prediction and analysis of human tissue-selective genes using microarray expression data , 2013, BMC Medical Genomics.

[55]  A. Malhotra,et al.  Pharmacogenetics of antipsychotics: recent progress and methodological issues , 2013, Expert opinion on drug metabolism & toxicology.

[56]  Richard A. Gibbs,et al.  Novel Genetic Loci Identified for the Pathophysiology of Childhood Obesity in the Hispanic Population , 2012, PloS one.

[57]  P. Mulholland,et al.  Chronic ethanol up-regulates the synaptic expression of the nuclear translational regulatory protein AIDA-1 in primary hippocampal neurons. , 2012, Alcohol.

[58]  Scott J. Russo,et al.  HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity , 2012, Nature Neuroscience.

[59]  R. Malenka,et al.  NMDA receptor-dependent long-term potentiation and long-term depression (LTP/LTD). , 2012, Cold Spring Harbor perspectives in biology.

[60]  R. Ritter.  A tale of two endings: Modulation of satiation by NMDA receptors on or near central and peripheral vagal afferent terminals , 2011, Physiology & Behavior.

[61]  A. Skol,et al.  Fine-mapping alleles for body weight in LG/J × SM/J F2 and F34 advanced intercross lines , 2011, Mammalian Genome.

[62]  G. Muscettola,et al.  Pattern of acute induction of Homer1a gene is preserved after chronic treatment with first- and second-generation antipsychotics: effect of short-term drug discontinuation and comparison with Homer1a-interacting genes , 2011, Journal of psychopharmacology.

[63]  E. Lange,et al.  Genome‐Wide Association Study of Anthropometric Traits and Evidence of Interactions With Age and Study Year in Filipino Women , 2011, Obesity.

[64]  Jeffrey A Lieberman,et al.  Genome-Wide Pharmacogenomic Study of Neurocognition As an Indicator of Antipsychotic Treatment Response in Schizophrenia , 2011, Neuropsychopharmacology.

[65]  H. Meltzer,et al.  The role of serotonin receptors in the action of atypical antipsychotic drugs. , 2011, Current opinion in pharmacology.

[66]  J. Coyle,et al.  Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia , 2011, Neuroscience & Biobehavioral Reviews.

[67]  R. Weinberg,et al.  Organization of amyloid‐β protein precursor intracellular domain‐associated protein‐1 in the rat brain , 2010, The Journal of comparative neurology.

[68]  G. Jenkins,et al.  A Genomewide Association Study of Citalopram Response in Major Depressive Disorder , 2010, Biological Psychiatry.

[69]  P. Mohler,et al.  Ankyrin protein networks in membrane formation and stabilization , 2009, Journal of cellular and molecular medicine.

[70]  A. Kurabi,et al.  A nuclear localization signal at the SAM-SAM domain interface of AIDA-1 suggests a requirement for domain uncoupling prior to nuclear import. , 2009, Journal of molecular biology.

[71]  Vladimir I. Vladimirov,et al.  Genomewide Pharmacogenomic Analysis of Response to Treatment with Antipsychotics , 2009, Molecular Psychiatry.

[72]  M. Kreutz,et al.  Nucleocytoplasmic protein shuttling: the direct route in synapse-to-nucleus signaling , 2009, Trends in Neurosciences.

[73]  S. Grant,et al.  PSD-95 Is Essential for Hallucinogen and Atypical Antipsychotic Drug Actions at Serotonin Receptors , 2009, The Journal of Neuroscience.

[74]  S. Grant,et al.  Targeted tandem affinity purification of PSD-95 recovers core postsynaptic complexes and schizophrenia susceptibility proteins , 2009, Molecular systems biology.

[75]  Marie-Claude Potier,et al.  Classification and basic pathology of Alzheimer disease , 2009, Acta Neuropathologica.

[76]  R. Ritter,et al.  NMDA NR2 receptors participate in CCK-induced reduction of food intake and hindbrain neuronal activation , 2009, Brain Research.

[77]  E. Ziff,et al.  Activity-dependent AIDA-1 nuclear signaling regulates nucleolar numbers and protein synthesis in neurons , 2007, Nature Neuroscience.

[78]  A. Deutch,et al.  p90 ribosomal S6 kinase 2 exerts a tonic brake on G protein-coupled receptor signaling. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[79]  J. Lieberman,et al.  Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. , 2005, The New England journal of medicine.

[80]  J. McGrath,et al.  A Systematic Review of the Prevalence of Schizophrenia , 2005, PLoS medicine.

[81]  Thomas A Neubert,et al.  Identification and Verification of Novel Rodent Postsynaptic Density Proteins*S , 2004, Molecular & Cellular Proteomics.

[82]  Anil K Malhotra,et al.  Pharmacogenetics of psychotropic drug response. , 2004, The American journal of psychiatry.

[83]  N. Swerdlow,et al.  Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review , 2001, Psychopharmacology.

[84]  S. Nakazawa,et al.  EB-1, a tyrosine kinase signal transduction gene, is transcriptionally activated in the t(1;19) subset of pre-B ALL, which express oncoprotein E2a-Pbx1 , 1999, Oncogene.

[85]  L. Tecott,et al.  Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene , 1998, Nature Medicine.

[86]  John Hardy,et al.  Amyloid, the presenilins and Alzheimer's disease , 1997, Trends in Neurosciences.

[87]  Christian Grillon,et al.  Gating and habituation of the startle reflex in schizophrenic patients. , 1992 .

[88]  M. Geyer,et al.  Prestimulus effects on human startle reflex in normals and schizophrenics. , 1978, Psychophysiology.

[89]  P. Riederer,et al.  Explorative results from multistep screening for potential genetic risk loci of Alzheimer’s disease in the longitudinal VITA study cohort , 2017, Journal of Neural Transmission.

[90]  F. Iasevoli,et al.  Serotonin–glutamate and serotonin–dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins , 2012, Psychopharmacology.

[91]  R. Weinberg,et al.  The organization of amyloid- β protein precursor intracellular domain-associated protein-1 in the rat forebrain , 2011 .

[92]  P. Vito,et al.  The intracellular localization of amyloid beta protein precursor (AbetaPP) intracellular domain associated protein-1 (AIDA-1) is regulated by AbetaPP and alternative splicing. , 2004, Journal of Alzheimer's Disease.

[93]  P. Vito,et al.  The intracellular localization of amyloid β protein precursor (AβPP) intracellular domain associated protein-1 (AIDA-1) is regulated by AβPP and alternative splicing , 2004 .